Hybrid Purifer Enhances Efficiency - - BioPharm International


Hybrid Purifer Enhances Efficiency

BioPharm International
Volume 27, Issue 8, pp. 44

3M’s Emphaze AEX Hybrid Purifier combines polymers, fine fiber nonwovens, and membranes to create an all-synthetic clarifying product line containing anion exchange nonwoven media and a fine particle, bioburden reduction membrane. The defined pore size of the qualifying membrane provides removal of insoluble particles below 0.1 μm in size, resulting in turbidity reduction.

In addition, the high chromatographic capacity of the Q-functional nonwoven provides reduction of negatively charged, soluble impurities including DNA and HCP. This combination of attributes allows the hybrid purifier to provide product purity before and after the Protein A column, enabling an easy post-Protein A monoclonal antibody (mAb) purification process.

According to the company, this purifier can improve the production of mAb drugs for various cancers, as well as autoimmune diseases such as rheumatoid arthritis and psoriasis.


blog comments powered by Disqus



First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here